Skip to content

Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®

Prolacta Compare. Growth and Weight Gain in Extremely Low Birth Weight Infants Fed an Exclusively Human Milk Based Diet With Prolacta®

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03886844
Enrollment
196
Registered
2019-03-22
Start date
2015-12-31
Completion date
2018-11-30
Last updated
2019-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extremely Low Birth Weight, Human Milk, Preterm Infants, Weight Gain

Keywords

Infant weight gain, Human milk fortifier, Preterm infants, ELBW infants

Brief summary

Preterm infants are susceptible to postnatal growth restriction. Breast milk is the recommended source of nutrition for preterm infants. As preterm infants have enhanced nutritional requirements, multicomponent fortifiers are added to breast milk in order to establish adequate growth. Due to the various benefits of human milk feds to preterm infants, a human milk fortifier based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been developed. With this study, the investigators want to evaluate the effect of human milk fortification on weight gain in extremely low birth weight infants (ELBW, \<1000g birth weight) in comparison to bovine fortification.

Detailed description

Preterm infants are susceptible to postnatal growth restriction. Breast milk is the recommended source of nutrition for preterm infants. Many positive short-term health effects like prevention necrotizing enterocolitis , effects on gut development and immunological issues are associated with breast milk feedings. The composition of breast milk usually meets the nutritional demands of term infants. As preterm infants have enhanced nutritional requirements, multicomponent fortifiers are added to breast milk in order to establish adequate growth and proper neurodevelopmental outcome. Due to the various benefits of human milk feds to preterm infants, a human milk fortifier based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been developed. This human milk fortifier contains more energy and protein than bovine milk fortifiers. So far, accurate data on growth and weight gain under an exclusive diet with human milk and the human milk fortifier Prolact+6H2MF®are missing. With this study, the investigators want to evaluate the impact of a human milk based fortifier on weight gain in extremely low birth weight infants (ELBW, \<1000g birth weight) in comparison to bovine milk based fortifier.

Interventions

DIETARY_SUPPLEMENTHuman milk fortifier based on human milk (Prolacta)

Intervention is started with an enteral intake of 100 ml/kg until 32 weeks corrected for prematurity, afterwards a human milk fortifier based on bovine milk is administered until estimated date of birth or 52 weeks corrected for prematurity (weight \<10. percentile) according to ESPGHAN(=European Society for paediatric gastroenterology, hepatology and nutrition) guidelines

Sponsors

Paracelsus Medical University
CollaboratorOTHER
Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 8 Weeks
Healthy volunteers
No

Inclusion criteria

* Preterm infants with a birth weight \<1000 g

Exclusion criteria

* Congenital heart disease * Major congenital birth defects * Major inborn error of metabolism

Design outcomes

Primary

MeasureTime frameDescription
growth velocity g/kg/d at 37+0 weeksat 37+0 weeks of gestationweight gain in g/kg/d

Secondary

MeasureTime frameDescription
growth velocity g/kg/d from start of fortification to 32+0 weeksat 32+0 weeks of gestationweight gain in g/kg/d
Weight at 32+0at 32 weeks of gestationweight in grams
Weight at 37+0at 37+0 weeks of gestationweight in grams
Length at 32+0at 32+0 weeks of gestationLength in cm
Length gain at 32+0at 32+0 weeks of gestationLength gain in cm/week
Head circumference at 32+0at 32+0 weeks of gestationhead circumference in cm
Head circumference gain at 32+0at 32+0 weeks of gestationhead circumference gain in cm/week
Length at 37+0at 37 weeks of gestationLength in cm
Lengthgain at 37+0at 37 weeks of gestationLengthgain in cm/week
growth velocity g/kg/d at 32+0 weeksat 32+0 weeks of gestationweight gain in g/kg/d
Head circumference gain at 37+0at 37 weeks of gestationHead circumference gain in cm/week
Time to full enteral feedsup to 37 weeks of gestationDay of life when full enteral feeds (140ml/kg) are tolerated
Incidence of necrotising enterocolitisup to 37 weeks of gestationNecrotizing enterocolitis stage 2a according to Bell
Body compositionup to 6 months corrected for prematurityFat and Fat- free mass measured by Body plethysmography
Blood parameter total proteinup to 37 weeks of gestationlaboratory parameter
Blood parameter Ureaup to 37 weeks of gestationlaboratory parameter
Blood parameter Triglycerideup to 37 weeks of gestationlaboratory parameter
Blood parameter Glucoseup to 37 weeks of gestationlaboratory parameter
z- scoresat 37 weeks of gestationz-scores for weight , length and head circumference
Head circumference at 37+0at 37 weeks of gestationHead circumference in cm

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026